Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
12.9M
-
Shares change
-
+2.11M
-
Total reported value, excl. options
-
$84.1M
-
Value change
-
+$15M
-
Put/Call ratio
-
0.08
-
Number of buys
-
36
-
Number of sells
-
-22
-
Price
-
$6.50
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2023
74 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q1 2023.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.9M shares
of 92.4M outstanding shares and own 14% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.04M shares), Avoro Capital Advisors LLC (2.65M shares), FMR LLC (1.36M shares), VANGUARD GROUP INC (1.12M shares), EAM Investors, LLC (209K shares), GEODE CAPITAL MANAGEMENT, LLC (181K shares), MILLENNIUM MANAGEMENT LLC (178K shares), MORGAN STANLEY (164K shares), BML Capital Management, LLC (150K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (136K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.